The pro-α1(V) collagen gene (Col5a1) is coordinately regulated by miR-29b with core promoter in cultured cells

References

• Gordon MK, Hahn RA. Collagens. Cell Tissue Res. 2010;339:247–257.
   PubMed Web of Science ®Google Scholar
• Ricard-Blum S. The collagen family. In: Hynes RO, Yamada KM, Eds.Extracellular matrix biology. New York: Cold Spring Harbor Laboratory Press; 2012. pp.45–64.
   Google Scholar
• Birk DE. Type V collagen: Heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron. 2001;32:223–237.
   PubMed Web of Science ®Google Scholar
• Chen S, Mienaltowski MJ, Brik DE. Regulation of corneal stroma extracellular matrix assembly. Exp Eye Res. 2015;133:69–80.
   PubMed Web of Science ®Google Scholar
• Fessler JH, Fessler LI. Structure and function of collagen types. In: Mayne R, Burgeson RE, Eds. Structure and function of collagen type. Orland, FL: Academic Press; 1987. pp.81–103.
   Google Scholar
• Sakata-Takatani K, Matsuo N, Sumiyoshi H, Tsuda T, Yoshioka H. Identification of a functional CBF-binding CCAAT-like motif in the core promoter of the mouse pro-α1 (V) collagen gene (Col5a1). Matrix Biol. 2004;23:87–99.
   PubMed Web of Science ®Google Scholar
• Wu YF, Matsuo N, Sumiyoshi H, Yoshioka H. The sp1 and CBF/NF-Y transcription factors cooperatively regulate the mouse pro-α3 (V) collagen gene (Col5a3) in osteoblastic cells. Acta Med Okayama. 2010a;64:95–108.
   PubMed Web of Science ®Google Scholar
• Wu YF, Matsuo N, Sumiyoshi H, Yoshioka H. Sp7/Osterix up-regulates the mouse pro-α3(V) collagen gene (Col5a3) during the osteoblast differentiation. Biochem Biophys Res Commun. 2010b;394:503–508.
   PubMed Web of Science ®Google Scholar
• Wu YF, Matsuo N, Sumiyoshi H, Yoshioka H. Sp7/Osterix is involved in the up-regulation of the mouse pro-α1(V) collagen gene (Col5a1) in osteoblastic cells. Matrix Biol. 2010c;29:701–706.
   PubMed Web of Science ®Google Scholar
• Colgan DF, Manley JL. Mechanism and regulation of mRNA polyadenylation. Genes Dev. 1997;11:2755–2766.
   PubMed Web of Science ®Google Scholar
• Ross J. mRNA stability in mammalian cells. Microbiol Rev. 1995;59:423–450.
   PubMedGoogle Scholar
• Lau NC, Lai EC. Diverse roles for RNA in gene regulation. Genome Biol. 2005;6:315.
   PubMedGoogle Scholar
• Matzke MA, Birchler JA. RNAi-mediated pathways in the nucleus. Nat Rev Genet. 2005;6:24–35.
   PubMed Web of Science ®Google Scholar
• Mazumder B, Seshadri V, Fox PL. Translational control by the 3′-UTR: The ends specify the means. Trends Biochem Sci. 2003;28:91–98.
   PubMed Web of Science ®Google Scholar
• Xie X, Lu J, Kulbokas E, Golub TR, Mootha V, Lindblad-Toh K, Lander ES, Kellis M. Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature. 2005;434:338–345.
   PubMed Web of Science ®Google Scholar
• Pasquinelli AE. MicroRNAs: Heralds of the noncoding RNA revolution. Rna. 2015;21:709–710.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297.
   PubMed Web of Science ®Google Scholar
• Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J, Koteliansky V, Rosenwald A, Basson MA, Licht JD, Pena JTR, Rouhanifard SH, Muckenthaler MU, Tuschl T, Martin GR, Bauersachs J, Engelhardt S. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signaling in fibroblasts. Nature. 2008;456:980–984.
   PubMed Web of Science ®Google Scholar
• Van Rooij E, Olson EN. MicroRNAs: Powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest. 2007;117:2369–2376.
   PubMed Web of Science ®Google Scholar
• Chung AC, Huang XR, Meng X, Lan HY. miR-192 mediates TGF-β/Smad3-driven renal fibrosis. J Am Soc Nephrol. 2010;21:1317–1325.
   PubMed Web of Science ®Google Scholar
• Van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Aci U S A. 2008;105:13027–13032.
   PubMed Web of Science ®Google Scholar
• Cushing L, Kuang PP, Qian J, Shao F, Wu J, Little F, Thannickal VJ, Cardoso WV, Lü J. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol. 2011;45:287–294.
   PubMed Web of Science ®Google Scholar
• Maurer B, Stanczyk J, Jüngel A, Akhmetshina A, Trenkmann M, Brock M, Kowal‐Bielecka O, Gay RE, Michel BA, Distler JH. MicroRNA‐29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum. 2010;62:1733–1743.
   PubMed Web of Science ®Google Scholar
• Ogawa T, Iizuka M, Sekiya Y, Yoshizato K, Ikeda K, Kawada N. Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem Biophys Res Commun. 2010;391:316–321.
   PubMed Web of Science ®Google Scholar
• Li N, Cui J, Duan X, Chen H, Fan F. Suppression of type I collagen expression by miR-29b via PI3K, Akt, and Sp1 pathway in human Tenon’s fibroblasts. Invest Ophthalmol Vis Sci. 2012;53:1670–1678.
   PubMed Web of Science ®Google Scholar
• Page PG, Stromberg AJ. Linear methods for analysis and quality control of relative expression ratios from quantitative real-time polymerase chain reaction experiments, Sci. World J. 2011;11:1383–1393.
   Web of Science ®Google Scholar
• Rutnam ZJ, Wight TN, Yang BB. miRNAs regulate expression and function of extracellular matrix molecules. Matrix Biol. 2013;32:74–85.
   PubMed Web of Science ®Google Scholar
• Zhang XY, Shen BR, Zhang YC, Wan XJ, Yao QP, Wu GL, Wang JY, Chen SG, Yan ZQ, Jiang ZL. Induction of thoracic aortic remodeling by endothelial-specific deletion of microRNA-21 in mice. Plos One. 2013;8:e59002.
   PubMed Web of Science ®Google Scholar
• Ji J, Zhao L, Budhu A, Forgues M, Jia HL, Qin LX, Ye QH, Yu J, Shi X, Tang ZY, Wang XW. Let-7g targets collagen type I α2and inhibits cell migration in hepatocellular carcinoma. J Hepatol. 2010;52:690–697.
   PubMed Web of Science ®Google Scholar
• Sengupta S, Den Boon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ, Chen CJ, Hildesheim A, Sugden B, Ahlquist P. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci USA. 2008;105:5874–5878.
   PubMed Web of Science ®Google Scholar
• Li H, Xie H, Liu W, Hu R, Huang B, Tan YF, Xu K, Sheng ZF, Zhou HD, Wu XP, Luo XH. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest. 2009;119:3666–3677.
   PubMed Web of Science ®Google Scholar
• Hu R, Lie W, Li H, Yang L, Chen C, Xia ZY, Guo LJ, Xie H, Zhou HD, Wu XP, Luo XH. Runx2/miR-3960/mir-2861 regulatory feedback loop during mouse osteoblast differentiation. J Biol Chem. 2011;286:12328–12339.
   PubMed Web of Science ®Google Scholar
• Wang X, Guo B, Li Q, Peng J, Yang Z, Wang A, Li D, Hou Z, Lv K, Kan G, Cao H, Wu H, Song J, Pan X, Sun Q, Ling S, Li Y, Zhu M, Zhang P, Peng S, Xie X, Tang T, Hong A, Bian Z, Bai Y, Lu A, Li Y, He F, Zhang G, Li Y. miR-214 targets ATF4 to inhibit bone formation. Nature Med. 2013;19:93–100.
   PubMed Web of Science ®Google Scholar
• Li Z, Hassan MQ, Jafferji M, Aqeilan RI, Garzon R, Croce CM, Van Wijnen AJ, Stein JL, Stein GS, Lian JB. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem. 2009;284:15676–15684.
   PubMed Web of Science ®Google Scholar
• Xiao J, Meng XM, Huang XR, Chung AC, Feng YL, Hui DS, Yu CM, Sung JJ, Lan HY. miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol Ther. 2012;20:1251–1260.
   PubMed Web of Science ®Google Scholar
• Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S, Janssen J, Koppe C, Knolle P, Castoldi M, Tacke F, Trautwein C, Luedde T. Micro‐RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology. 2011;53:209–218.
   PubMed Web of Science ®Google Scholar
• Yan B, Guo Q, Fu F, Wang Z, Yin Z, Wei YB, Yang JR. The role of miR-29b in cancer: regulation, function, and signaling. Onco Targets Ther. 2015;8:539–548.
   PubMed Web of Science ®Google Scholar
• Tan M, Wu J, Cai Y. Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer. Biochem Biophys Res Commun. 2013;438:673–679.
   PubMed Web of Science ®Google Scholar
• Ramirez F, Tanaka S, Bou-Gharios G. Transcriptional regulation of the human α2(I) collagen gene (COL1A2), an informative model system to study fibrotic disease. Matrix Biol. 2006;25:365–372.
   PubMed Web of Science ®Google Scholar
• Yang T, Liang Y, Lin Q, Liu J, Luo F, Li X, Zhou H, Zhuang S, Zhang H. MiR‐29 mediates TGFβ1‐induced extracellular matrix synthesis through activation of PI3K‐AKT pathway in human lung fibroblasts. J Cell Biochem. 2013;114:1336–1342.
   PubMed Web of Science ®Google Scholar
• Liu GX, Li YQ, Huang XR, Wei L, Chen HY, Shi YJ, Heuchel RL, Lan HY. Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF κB-dependent mechanisms in mice. PLoS One. 2013;8:e53573.
   PubMed Web of Science ®Google Scholar
• Kahai S, Vary CPH, Gao Y, Seth A. Collagen, type V, α1 (COL5A1) is regulated by TGF-β in osteoblasts. Matrix Biol. 2004;23:445–455.
   PubMed Web of Science ®Google Scholar
• Mak KM, Png CYM, Lee DJ. Type V collagen in health, disease, and fibrosis. Anat Record. 2016;299:613–629.
   Google Scholar